TW200606178A - Cyclopeptide derivatives with anti-integrin activity - Google Patents
Cyclopeptide derivatives with anti-integrin activityInfo
- Publication number
- TW200606178A TW200606178A TW094114404A TW94114404A TW200606178A TW 200606178 A TW200606178 A TW 200606178A TW 094114404 A TW094114404 A TW 094114404A TW 94114404 A TW94114404 A TW 94114404A TW 200606178 A TW200606178 A TW 200606178A
- Authority
- TW
- Taiwan
- Prior art keywords
- compounds
- inhibitors
- integrin activity
- cyclopeptide derivatives
- integrin
- Prior art date
Links
- 102000001189 Cyclic Peptides Human genes 0.000 title 1
- 108010069514 Cyclic Peptides Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 102000006495 integrins Human genes 0.000 abstract 2
- 108010044426 integrins Proteins 0.000 abstract 2
- 208000009304 Acute Kidney Injury Diseases 0.000 abstract 1
- 208000031104 Arterial Occlusive disease Diseases 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000033626 Renal failure acute Diseases 0.000 abstract 1
- 208000017442 Retinal disease Diseases 0.000 abstract 1
- 206010038923 Retinopathy Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 201000011040 acute kidney failure Diseases 0.000 abstract 1
- 208000012998 acute renal failure Diseases 0.000 abstract 1
- 208000021328 arterial occlusion Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000239A ITRM20040239A1 (it) | 2004-05-13 | 2004-05-13 | Derivati ciclopeptidici ad attivita' antintegrine. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200606178A true TW200606178A (en) | 2006-02-16 |
Family
ID=34968013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094114404A TW200606178A (en) | 2004-05-13 | 2005-05-04 | Cyclopeptide derivatives with anti-integrin activity |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20070178045A1 (enExample) |
| EP (1) | EP1751176B1 (enExample) |
| JP (1) | JP2008500971A (enExample) |
| KR (1) | KR20070012524A (enExample) |
| CN (1) | CN1953990A (enExample) |
| AR (1) | AR048957A1 (enExample) |
| AT (1) | ATE460426T1 (enExample) |
| AU (1) | AU2005243418A1 (enExample) |
| BR (1) | BRPI0510985A (enExample) |
| CA (1) | CA2562576A1 (enExample) |
| CY (1) | CY1110039T1 (enExample) |
| DE (1) | DE602005019876D1 (enExample) |
| DK (1) | DK1751176T3 (enExample) |
| ES (1) | ES2340862T3 (enExample) |
| HR (1) | HRP20100301T1 (enExample) |
| IT (1) | ITRM20040239A1 (enExample) |
| MX (1) | MXPA06012887A (enExample) |
| PL (1) | PL1751176T3 (enExample) |
| PT (1) | PT1751176E (enExample) |
| RS (1) | RS51300B (enExample) |
| SI (1) | SI1751176T1 (enExample) |
| TW (1) | TW200606178A (enExample) |
| WO (1) | WO2005111064A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI474819B (zh) * | 2012-05-15 | 2015-03-01 | Univ Nat Cheng Kung | 調控物及含有該調控物之醫藥組合物 |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2640013A1 (en) * | 2006-02-09 | 2007-08-16 | Enzon Pharmaceuticals, Inc. | Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
| EP1961759A1 (en) * | 2007-02-21 | 2008-08-27 | Universita'degli Studi Di Milano | Integrin targeted cyclopeptide ligands, their preparation and use |
| MX2015011670A (es) * | 2013-03-15 | 2016-03-31 | Biogen Ma Inc | Tratamiento y prevencion de lesion renal aguda usando anticuerpos anti-alfa v beta 5. |
| CN103588863B (zh) * | 2013-11-15 | 2016-08-17 | 苏州强耀生物科技有限公司 | Rgd环肽合成制备工艺 |
| WO2022183360A1 (en) * | 2021-03-02 | 2022-09-09 | Tsao Yeou Ping | Short synthetic peptide and their uses for treating dry eye disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4310643A1 (de) * | 1993-04-01 | 1994-10-06 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
| US5449761A (en) * | 1993-09-28 | 1995-09-12 | Cytogen Corporation | Metal-binding targeted polypeptide constructs |
| US6027711A (en) * | 1995-06-07 | 2000-02-22 | Rhomed Incorporated | Structurally determined metallo-constructs and applications |
| DE19725368A1 (de) * | 1997-06-16 | 1998-12-17 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren und deren Verwendung für bildgebende Verfahren |
| ITRM20040242A1 (it) * | 2004-05-13 | 2004-08-13 | Ist Naz Stud Cura Dei Tumori | "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine. |
| ITRM20040240A1 (it) * | 2004-05-13 | 2004-08-13 | Ist Naz Stud Cura Dei Tumori | Camptotecine coniugate in posizione 7 con antagonisti delle integrine. |
-
2004
- 2004-05-13 IT IT000239A patent/ITRM20040239A1/it unknown
-
2005
- 2005-05-04 EP EP05742999A patent/EP1751176B1/en not_active Expired - Lifetime
- 2005-05-04 RS RSP-2010/0231A patent/RS51300B/sr unknown
- 2005-05-04 DK DK05742999.5T patent/DK1751176T3/da active
- 2005-05-04 MX MXPA06012887A patent/MXPA06012887A/es active IP Right Grant
- 2005-05-04 PL PL05742999T patent/PL1751176T3/pl unknown
- 2005-05-04 SI SI200530986T patent/SI1751176T1/sl unknown
- 2005-05-04 HR HR20100301T patent/HRP20100301T1/hr unknown
- 2005-05-04 JP JP2007512736A patent/JP2008500971A/ja not_active Withdrawn
- 2005-05-04 AU AU2005243418A patent/AU2005243418A1/en not_active Abandoned
- 2005-05-04 CA CA002562576A patent/CA2562576A1/en not_active Abandoned
- 2005-05-04 TW TW094114404A patent/TW200606178A/zh unknown
- 2005-05-04 WO PCT/IT2005/000262 patent/WO2005111064A1/en not_active Ceased
- 2005-05-04 US US11/596,190 patent/US20070178045A1/en not_active Abandoned
- 2005-05-04 PT PT05742999T patent/PT1751176E/pt unknown
- 2005-05-04 CN CNA2005800152380A patent/CN1953990A/zh active Pending
- 2005-05-04 AT AT05742999T patent/ATE460426T1/de not_active IP Right Cessation
- 2005-05-04 KR KR1020067025228A patent/KR20070012524A/ko not_active Ceased
- 2005-05-04 BR BRPI0510985-0A patent/BRPI0510985A/pt not_active IP Right Cessation
- 2005-05-04 DE DE602005019876T patent/DE602005019876D1/de not_active Expired - Lifetime
- 2005-05-04 ES ES05742999T patent/ES2340862T3/es not_active Expired - Lifetime
- 2005-05-13 AR ARP050101955A patent/AR048957A1/es unknown
-
2010
- 2010-05-19 CY CY20101100440T patent/CY1110039T1/el unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI474819B (zh) * | 2012-05-15 | 2015-03-01 | Univ Nat Cheng Kung | 調控物及含有該調控物之醫藥組合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1751176A1 (en) | 2007-02-14 |
| WO2005111064A8 (en) | 2006-02-09 |
| ES2340862T3 (es) | 2010-06-10 |
| EP1751176B1 (en) | 2010-03-10 |
| AU2005243418A1 (en) | 2005-11-24 |
| BRPI0510985A (pt) | 2007-12-04 |
| AR048957A1 (es) | 2006-06-14 |
| RS51300B (sr) | 2010-12-31 |
| HRP20100301T1 (hr) | 2010-06-30 |
| DK1751176T3 (da) | 2010-06-14 |
| CY1110039T1 (el) | 2012-05-23 |
| CA2562576A1 (en) | 2005-11-24 |
| PL1751176T3 (pl) | 2010-08-31 |
| ITRM20040239A1 (it) | 2004-08-13 |
| SI1751176T1 (sl) | 2010-06-30 |
| ATE460426T1 (de) | 2010-03-15 |
| MXPA06012887A (es) | 2007-02-15 |
| DE602005019876D1 (de) | 2010-04-22 |
| US20070178045A1 (en) | 2007-08-02 |
| CN1953990A (zh) | 2007-04-25 |
| JP2008500971A (ja) | 2008-01-17 |
| KR20070012524A (ko) | 2007-01-25 |
| WO2005111064A1 (en) | 2005-11-24 |
| PT1751176E (pt) | 2010-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011007065A (es) | Analogos de dicetopiperazina substituida para usarse como agentes de suministro de farmaco. | |
| TR200201636T2 (tr) | Sübstitüe edilmiş oksazolidinonlar ve bunların kullanımı | |
| Self et al. | Renin-angiotensin system modulation with synthetic angiotensin (1-7) and angiotensin II type 1 receptor–biased ligand in adults with COVID-19: two randomized clinical trials | |
| CY1112376T1 (el) | Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2 | |
| GB0222495D0 (en) | Compounds | |
| ES2340179T3 (es) | Antagonistas de urea del receptor p2y1 utiles en el tratamiento de afecciones tromboticas. | |
| CY1112646T1 (el) | Θεραπευτικες χρησεις ενωσεων που εχουν συνδυασμενη δραστικοτητα sert, 5-ητ3 και 5-ητ1α | |
| CY1111454T1 (el) | Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων | |
| WO2016115275A1 (en) | Ctla4-binding protein peptide-linker masks | |
| EP2775906A1 (en) | Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging | |
| MX2012013879A (es) | Derivados de hidroxipiridona, composiciones farmceuticas de los mismos y su uso terapeutico para tratar enfermedades proliferativas. | |
| Mohan et al. | Management of cutaneous and extracutaneous side effects of smoothened inhibitor therapy for advanced basal cell carcinoma | |
| TW200606178A (en) | Cyclopeptide derivatives with anti-integrin activity | |
| Kongkamnerd et al. | Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus | |
| ATE384529T1 (de) | Synergistische kombination enthaltend roflumilast und einen anticholinergischen wirkstoff ausgewählt aus tiotropiumsalzen für die behandlung von atemwegserkrankungen | |
| DE602006020871D1 (de) | Lineare harnstoffmimetika-antagonisten des p2y1-rezeptors zur behandlung von thromboseleiden | |
| WO2004011487A8 (en) | Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity | |
| MY148254A (en) | Tartrate derivatives for use as coagulation factor ixa inhibitors | |
| BRPI0511639A (pt) | pirrolidin-2-onas substituìdas | |
| MY160963A (en) | Sustained-release therapeutic agent for hypertension and renal dysfunction | |
| US20220280491A1 (en) | Septin inhibitors for treatment of cancers | |
| EP2039354A4 (en) | COMPOUND WITH EFFECT TO BLOCK THE NMDA RECEPTOR CHANNEL AND THEREOF CONTAINING PHARMACEUTICAL AGENT | |
| EA201391348A8 (ru) | КОМБИНАЦИИ АКТИВАТОРОВ АЛЬФА-7 НИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА И АНТАГОНИСТОВ mGluR5, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ПРИМЕНЕНИЯ ПРИ ВЫЗВАННОЙ ДОПАМИНОМ ДИСКИНЕЗИИ, СВЯЗАННОЙ С БОЛЕЗНЬЮ ПАРКИНСОНА | |
| BRPI0406884A (pt) | Derivados de diazepans úteis como inibidores de lfa | |
| WO2022197866A1 (en) | Anti-hvem antibodies |